Parmax Pharma Ltd
BSE: 540359
values in crores
Revenue & Profit Trend
in croresRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q3 FY2026 | Q2 FY2026 | Q1 FY2026 | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 |
|---|---|---|---|---|---|---|
| INCOME | ||||||
| Revenue | 4.33+70.9% | 2.53+30.3% | 1.94-59.8% | 4.83-23.2% | 6.28-32.3% | 9.28 |
| Other Income | 0.01+2.9% | 0.01+4.5% | 0.01+106.9% | -0.10-851.5% | 0.01-88.9% | 0.12 |
| Total Income | 4.33+70.7% | 2.54+30.2% | 1.95-58.8% | 4.73-24.9% | 6.30-33.0% | 9.39 |
| EXPENSES | ||||||
| Expenditure | 5.06+9.7% | 4.62+70.1% | 2.71-50.2% | 5.45-18.5% | 6.69-30.4% | 9.61 |
| Tax | 0.00 | 0.00 | 0.00+100.0% | -0.30 | — | — |
| PROFIT | ||||||
| PBT | -0.73+64.8% | -2.08-171.9% | -0.76+57.4% | -1.80-354.7% | -0.40-82.0% | -0.22 |
| Net Profit | -0.73+64.8% | -2.08-171.9% | -0.76+48.9% | -1.49-278.5% | -0.40-82.0% | -0.22 |
| KEY METRICS | ||||||
| OPM % | -4.56%+58.25pp | -62.81%-49.94pp | -12.87%+21.06pp | -33.93%-19.24pp | -14.69%-5.36pp | -9.33% |
| NPM % | -16.89%+65.01pp | -81.90%-42.67pp | -39.23%-7.61pp | -31.62%-25.35pp | -6.27%-3.96pp | -2.31% |
| EPS | 1.96-64.7% | 5.56+172.5% | 2.04-49.0% | 4.00+481.0% | -1.05-81.0% | -0.58 |
Corporate Events
Board MeetingPARMAX
20262Jul
Board Meeting
The Extraordinary General Meeting (EGM) of the Company is sc…
BSE Filing ↗ Board MeetingPARMAX
20268Jun
Board Meeting
The board meeting is scheduled to consider and approve fund …
BSE Filing ↗ Board MeetingPARMAX
202630May
Board Meeting
The board meeting is scheduled to consider and approve the a…
BSE Filing ↗ Board MeetingPARMAX
202515Nov
Board Meeting
Reschedule of Board Meeting, Approve and consider unaudited …
BSE Filing ↗ Board MeetingPARMAX
202514Aug
Board Meeting
Consider and approve un-audited standalone financial results
BSE Filing ↗